Oxbridge Re Holdings Ltd.
Oxbridge Re Holdings Ltd. Q3 FY2024 earnings call
November 13, 2024 · fiscal period ended 2024-09
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2024-11-13
Management highlights
- In December 2022, established SurancePlus to tokenize securities. - In Q2 2023, concluded initial offering of Delta CatRe on Avalanche blockchain, which exceeded initial projections despite Hurricane Idalia. - SurancePlus completed private placement of over $2.9 million via Digital Token EpsilonCat Re. - Oxbridge Re Holdings initiated strategic review process for company and SurancePlus, considering alternatives like sale, spin-off, merger, etc. - SurancePlus partnered with Zoniqx to enhance RWA tokenization and Web3 capabilities.
Segment performance
For the quarter ended September 30, 2024, net premiums earned were $595,000 compared to $549,000 in Q3 2023. For the first nine months of 2024, net premiums earned were $1.7 million, up from $730,000 in the same period 2023. Reinsurance business had a loss ratio of 0% in both 2024 and 2023. Acquisition cost ratio for Q3 2024 was 11.1% (up from 10.9% in Q3 2023) and 11% for 1-9 months 2024 (up from 10.9% in 1-9 months 2023). Expense ratio for Q3 2024 decreased to 83.7% from 125.3% in Q3 2023, and for 1-9 months 2024, it decreased to 19% from 244.3% in 1-9 months 2023. Combined ratio for Q3 2024 was 83.7% (down from 125.3% in Q3 2023) and for 1-9 months 2024, it was 90% (down from 44.3% in 1-9 months 2023). SurancePlus contributed management fee income. Investment portfolio decreased, cash and cash equivalents increased.
Guidance
- Oxbridge Re Holdings has a strategic review process forming a special committee to consider strategic alternatives for the company and SurancePlus. - Anticipate providing further updates on progress during next call.
Risks
- Forward-looking statements are subject to various risks and uncertainties detailed in Form 10-K and 10-Q, which could materially affect business, financial condition, and earnings volatility.
Q&A highlights
Q: How are you all being received on the presentations abroad and who are your competitors in the RWA space?
A: The presentations were viewed exceedingly well. In the RWA space, there are competitors, but Oxbridge Re stands out due to having PCOB audited financials on SurancePlus and strict SEC adherence.
Q: Your immediate reaction to earnings report is positive on bid and offering sides. Any comment?
A: Thank you, Kent. Appreciate it.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | — | — | — | — |
| Revenue | — | — | — | — |
Transcript
November 13, 2024Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.